Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ONMD - .7903 Pre-market at .8918/.90
OneMedNet Announces It Entered A Securities Purchase Agreement Dated Mar. 28 Providing Up To $4.54M In Funding Through Private Placement Of Senior Convertible Notes
CYTH - 1.66 Up .30 already and moving.....news out at 2:30 eastern
Cyclo Therapeutics Receives Decision To Grant European Patent Titled 'METHODS FOR TREATING ALZHEIMER'S DISEASE WITH HP-[BETA]-CYCLODEXTRIN'
LIFW - .667 Pre-market at 1.21/1.22
MSP Recovery, Inc. 13G Filing Shows Palantir Technologies Inc. Reported A 6.5% Stake In The Co As Of March 22, 2024
SGRP - .9696 Pre-market at 1.32/1.34
SPAR Group Announces Sale Of Interest In South Africa And Brazil For Combined Cash Proceeds Of ~$22M
SBFM - .0605 Pre-market at .099/.0998
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Small stocks with early strong interest:
MDIA
NKLA
GRTX
XLO
MESO
EQ
Early movers:
AKBA
AKAN
XLO
IBIO
AVTX
BCAN
LIXT - 2.255 Pre-market at 3.67/3.69
NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
HOTH - 2.00 Up .51 with today's news.
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
PIXY - 2.98 Pre-market at 3.12/3.19
ShiftPixy Announces Agreement To Acquire A Provider Of Human Capital, Which Has Annual Revenue Run Rate Revenue Of $58M; Terms Not Disclosed
MRDB - .226 Pre-market at .4134/.4149
MariaDB shares are trading higher after Progress Software announced that it is possibly considering an offer for the company.
IBIO - 1.15 Pre-market at 2.10/2.12
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
VERB - .28 Pre-market at .434/.4354
VERB's MARKET.live Enters Into Formal Partnership With TikTok for Livestream Shopping Services
LCID - 2.92 Pre-market at 2.97/2.99
MW EV maker Lucid Group rallies on heavy volume after $1 billion investment by majority stockholder
VKTX - 69.19 Pre-market at 80.71/81
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
SOUN - 5.86 Pre-market at 6.25/6.26
SoundHound AI's Voice Assistant With Integrated ChatGPT Launches In Stellantis DS Automobiles
MESO - 2.20 Pre-market at 2.85/2.87
Mesoblast shares are trading higher after the FDA informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L for treatment of pediatric patients with steroid-refractory acute graft versus host disease.
ABVC - 1.05 Pre-market at 1.57/1.58
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
CHEK - 1.965 Pre-market at 2.56/2.57
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement
OPGN - .475 Pre-market at .76/.7631
OpGen shares are trading higher after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO.
Small cap stocks with early strong interest:
OPGN
CHEK
KULR
MESO
SOUN
ABVC
OCGN
LICY
XTLB
Doctors appointment today.....Posted this up on X earlier:
Stocks with strong interest in the AM:
CYTO
LCID
XTLB
OCGN
MLGO
MARA
CLSK
WULF
FRGE
RIOT
IREN
RIG
BTBT
IDN
LAC
OTLK - 7.04 Pre-market at 10.35/10.45
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
OKYO - 1.76 Pre-market at 1.91/1.92
OKYO Pharma shares are trading higher after the company's OK-101 achieved statistical significance for multiple signs and symptoms of dry eye disease in its first-in-human Phase 2 trial.
NVFY - 1.85 Pre-market at 3.13/3.15
Shares of furniture, home goods and decor retailers are trading higher amid overall market strength. Housing-related stocks may also be reacting to Wednesday's Fed decision and better-than-expected February U.S. existing home sales.
BIOL - .15 Pre-market at .2453/.2456
Biolase Anticipates Q1 Net Revenue To Exceed $10M, Relatively Flat Y/Y (Est $10.796M); 2024 Net Revenue To Increase 6%-8% To $52M-$53M (Est $53.068M)
LASE - 1.54 Pre-market at 1.77/1.78
Laser Photonics shares are trading higher after announcing a distribution agreement with Incredible Supply & Logistics for its military and industrial laser solutions.
YTEN - .243 Pre-market at .5551/.5572
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
KAVL - 1.33 Pre-market at 2.16/2.17
US Futures Trend Higher After Fed Decision to Hold Interest Rates Steady
ASST - .505 Pre-market at .8801/.8834
Asset Entities Inc. Enters Into Agreement with Zendrop, the "#1 High Margin Dropshipping App"
RIOT - 11.09 Pre-market at 11.52/11.60
ATOS - 1.55 Pre-market at 1.63/1.64
Atossa Therapeutics shares are trading higher after the company provided a five-year on a breast cancer patient who received neoadjuvant and adjuvant (Z)-endoxifen therapy.
CGC - 3.83 Pre-market at 4.32/4.35
Shares of cannabis stocks are trading higher after VP Kamala Harris recently urged the DEA to reschedule marijuana.
NLSP - .2694 Pre-market at .417/419
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
HOTH - 1.41 Up .26 News just out...stock moving higher.
Hoth Therapeutics Says HT-ALZ Emerges As A Promising Novel Solution For Combating Neuroinflammation And Cognitive Deficits Associated With Alzheimer's Disease.
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
NCMI - 4.22 Pre-market at 5.27/5.30
National CineMedia shares are trading higher after the company reported better-than-expected Q4 financial results and announced a $100 million share repurchase program.
B. Riley Securities Upgrades National CineMedia to Buy, Raises Price Target to $6.75
CATX - .965 Pre-market at 1.21/1.22
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
ENVB - 1.10 Pre-market at 1.38/1.39
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |